These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 10918432

  • 1. Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation.
    Spitzer TR, Friedman CJ, Bushnell W, Frankel SR, Raschko J.
    Bone Marrow Transplant; 2000 Jul; 26(2):203-10. PubMed ID: 10918432
    [Abstract] [Full Text] [Related]

  • 2. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
    Fox-Geiman MP, Fisher SG, Kiley K, Fletcher-Gonzalez D, Porter N, Stiff P.
    Biol Blood Marrow Transplant; 2001 Jul; 7(11):596-603. PubMed ID: 11760147
    [Abstract] [Full Text] [Related]

  • 3. The use of oral granisetron versus intravenous ondansetron for antiemetic prophylaxis in patients undergoing laparoscopic surgery: the effect on emetic symptoms and quality of recovery.
    White PF, Tang J, Hamza MA, Ogunnaike B, Lo M, Wender RH, Naruse R, Sloninsky A, Kariger R, Cunneen S, Khalili T.
    Anesth Analg; 2006 May; 102(5):1387-93. PubMed ID: 16632815
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
    Chiou TJ, Tzeng WF, Wang WS, Yen CC, Fan FS, Liu JH, Chen PM.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
    [Abstract] [Full Text] [Related]

  • 5. Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.
    Walsh T, Morris AK, Holle LM, Callander N, Bradshaw P, Valley AW, Clark G, Freytes CO.
    Bone Marrow Transplant; 2004 Dec; 34(11):963-8. PubMed ID: 15489869
    [Abstract] [Full Text] [Related]

  • 6. Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation.
    Abbott B, Ippoliti C, Bruton J, Neumann J, Whaley R, Champlin R.
    Bone Marrow Transplant; 1999 Feb; 23(3):265-9. PubMed ID: 10084258
    [Abstract] [Full Text] [Related]

  • 7. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
    Slabý J, Trnený M, Procházka B, Klener P.
    Neoplasma; 2000 Feb; 47(5):319-22. PubMed ID: 11130251
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
    Burris H, Hesketh P, Cohn J, Moriconi W, Ryan T, Friedman C, Fitts D.
    Cancer J Sci Am; 1996 Feb; 2(2):85-90. PubMed ID: 9166505
    [Abstract] [Full Text] [Related]

  • 9. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
    Jeremić B.
    Srp Arh Celok Lek; 1996 Feb; 124(5-6):131-4. PubMed ID: 9102832
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy.
    Ettinger DS, Eisenberg PD, Fitts D, Friedman C, Wilson-Lynch K, Yocom K.
    Cancer; 1996 Jul 01; 78(1):144-51. PubMed ID: 8646710
    [Abstract] [Full Text] [Related]

  • 12. Granisetron and ondansetron for chemotherapy-related nausea and vomiting.
    Zeidman A, Ben Dayan D, Ben Zion T, Kaufman O, Cohen AM, Mittelman M.
    Haematologia (Budap); 1998 Jul 01; 29(1):25-31. PubMed ID: 9704254
    [Abstract] [Full Text] [Related]

  • 13. [Value of the combination of oral ondansetron with methylprednisolone as soon as the first cure in mild emetogenic chemotherapy. Groupe français d'étude de l'ondansétron].
    Coiffier B, Khayat D, Misset JL, Votan B.
    Bull Cancer; 1997 Aug 01; 84(8):781-7. PubMed ID: 9339181
    [Abstract] [Full Text] [Related]

  • 14. [Comparative trial of oral granisetron and intravenous ondansetron in patients receiving chemotherapy for breast cancer. Study Group of Granisetron].
    Mabro M, Granisétron PK.
    Bull Cancer; 1999 Mar 01; 86(3):295-301. PubMed ID: 10210764
    [Abstract] [Full Text] [Related]

  • 15. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
    Poli-Bigelli S, Rodrigues-Pereira J, Carides AD, Julie Ma G, Eldridge K, Hipple A, Evans JK, Horgan KJ, Lawson F, Aprepitant Protocol 054 Study Group.
    Cancer; 2003 Jun 15; 97(12):3090-8. PubMed ID: 12784346
    [Abstract] [Full Text] [Related]

  • 16. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W, Mo FK, Suen JJ, Ho WM, Chan SL, Lau W, Koh J, Yeung WK, Kwan WH, Lee KK, Mok TS, Poon AN, Lam KC, Hui EK, Zee B.
    Breast Cancer Res Treat; 2009 Feb 15; 113(3):529-35. PubMed ID: 18327706
    [Abstract] [Full Text] [Related]

  • 17. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
    Aksoylar S, Akman SA, Ozgenç F, Kansoy S.
    Pediatr Hematol Oncol; 2001 Sep 15; 18(6):397-406. PubMed ID: 11554235
    [Abstract] [Full Text] [Related]

  • 18. [Acute tolerance in hyperfractionated accelerated whole-body irradiation].
    Latz D, Schraube P, Wannenmacher M.
    Strahlenther Onkol; 1996 Dec 15; 172(12):685-9. PubMed ID: 8992638
    [Abstract] [Full Text] [Related]

  • 19. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
    Chawla SP, Grunberg SM, Gralla RJ, Hesketh PJ, Rittenberg C, Elmer ME, Schmidt C, Taylor A, Carides AD, Evans JK, Horgan KJ.
    Cancer; 2003 May 01; 97(9):2290-300. PubMed ID: 12712486
    [Abstract] [Full Text] [Related]

  • 20. [Value of granisetron in the prevention of digestive disorders in total body irradiation].
    Feuvret L, Jammet P, Campana F, Cosset JM, Fourquet A.
    Bull Cancer Radiother; 1994 May 01; 81(1):41-4. PubMed ID: 7893522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.